Category Archives: Public Policy

Latest From Public Policy

Seventy Nine House Members Express Concern with H.R. 9

Vote No on HR 9

House leaders made the decision earlier this month to remove patent reform legislation from the schedule for the remaining days before the August recess. While a vote is expected to occur sometime in September, House Majority Leader Kevin McCarthy made the decision to review and address many of the concerns that have been voiced by an array of industries that require the value of dependable and enforceable patents. In the words of Representative McCarthy, “I Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

CNBC Commentary: Hedge funds, ‘reverse trolls’ crushing biopharma innovation

Vote No on HR 9

Patents are the lifeblood of medical innovation. They are the cornerstone that enables companies to perform the long and costly research and development for cures and therapies to combat devastating diseases such as cancer, HIV and Alzheimer’s. Unfortunately, the system that helps protect these innovations is being abused by outside interests. BIO and others have called upon Congress to fix these problems as part of a greater patent reform debate. Today one more voice joined Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Letter of Support for 21st Century Cures Legislation

21st Century Cures Act

Today, BIO sent a letter to Reps. Boehner and Pelosi in support of the 21st Century Cures Act. In the letter, we applaud Chairman Upton, Ranking Member Pallone and Congresswoman DeGette’s efforts on H.R. 6., which takes important steps toward placing patients at the center of the drug development process. We also expressed support for precision medicine through genomics and regulatory science to help better understand the molecular basis of disease and develop precision therapies tailored to each Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Understanding the Wider Implications of HR 9: Patent Reform’s Impact on Agriculture

US_Patent_And_Trademark_Office

The House Judiciary Committee recently approved H.R. 9, the Innovation Act, legislation they hoped would reduce frivolous patent-related litigation, frequently filed by so-called “patent trolls.”  Unfortunately, rather than surgically targeting abusive lawsuits, H.R. 9 would fundamentally alter the ability of legitimate patent holders to defend their rights. Agricultural innovation, biotechnology and sustainable agriculture will help society meet monumental challenges presented by the expected growth in demand for animal feed, food, fibers, biofuels and pharmaceuticals.  However, Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

IP Sessions at BIO 2015: The Evolving Landscape of Patentable Subject Matter

patent

The IP Track at BIO 2015 had a number of incredible educational sessions concerning the most relevant topics in the biotech sector. Let’s look back at what top experts in the IP field had to say about the changing nature of patentable subject matter: Panelists included: Jennifer Swan and Howard Levine, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Raul Tamayo, USPTO P. Michael Walker, E.I. du Pont de Nemours and Company Panelists focused on the increasingly restrictive interpretation of patent eligibility, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , ,